Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q3 Loss, Tops Revenue Estimates
Portfolio Pulse from
Ginkgo Bioworks Holdings, Inc. (DNA) reported a Q3 loss of $1.08 per share, which was better than the Zacks Consensus Estimate of a $2.40 loss. This is an improvement from the $3.60 loss per share reported a year ago.
November 13, 2024 | 1:15 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ginkgo Bioworks reported a Q3 loss of $1.08 per share, better than the expected $2.40 loss, showing improvement from last year's $3.60 loss per share.
The better-than-expected earnings report, with a loss of $1.08 per share compared to the expected $2.40, suggests positive investor sentiment and potential short-term stock price increase. The improvement from last year's loss also indicates progress.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100